230 related articles for article (PubMed ID: 27773784)
21. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer.
Zhang I; Zaorsky NG; Palmer JD; Mehra R; Lu B
Lancet Oncol; 2015 Oct; 16(13):e510-21. PubMed ID: 26433824
[TBL] [Abstract][Full Text] [Related]
22. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
[TBL] [Abstract][Full Text] [Related]
23. The role of systemic and targeted therapies in brain metastases.
Franceschi E; Bartolotti M; Poggi R; Di Battista M; Palleschi D; Brandes AA
Expert Rev Anticancer Ther; 2014 Jan; 14(1):93-103. PubMed ID: 24308678
[TBL] [Abstract][Full Text] [Related]
24. Systemic therapies for melanoma brain metastases: which drug for whom and when?
Ramanujam S; Schadendorf D; Long GV
Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
[TBL] [Abstract][Full Text] [Related]
25. ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.
Charmsaz S; Doherty B; Cocchiglia S; Varešlija D; Marino A; Cosgrove N; Marques R; Priedigkeit N; Purcell S; Bane F; Bolger J; Byrne C; O'Halloran PJ; Brett F; Sheehan K; Brennan K; Hopkins AM; Keelan S; Jagust P; Madden S; Martinelli C; Battaglini M; Oesterreich S; Lee AV; Ciofani G; Hill ADK; Young LS
BMC Med; 2020 Nov; 18(1):349. PubMed ID: 33208158
[TBL] [Abstract][Full Text] [Related]
26. Unsanctifying the sanctuary: challenges and opportunities with brain metastases.
Puhalla S; Elmquist W; Freyer D; Kleinberg L; Adkins C; Lockman P; McGregor J; Muldoon L; Nesbit G; Peereboom D; Smith Q; Walker S; Neuwelt E
Neuro Oncol; 2015 May; 17(5):639-51. PubMed ID: 25846288
[TBL] [Abstract][Full Text] [Related]
27. Genetic Characterization of Brain Metastases in the Era of Targeted Therapy.
Han CH; Brastianos PK
Front Oncol; 2017; 7():230. PubMed ID: 28993799
[TBL] [Abstract][Full Text] [Related]
28. Targeted Therapy in Brain Metastases: Ready for Primetime?
Venur VA; Ahluwalia MS
Am Soc Clin Oncol Educ Book; 2016; 35():e123-30. PubMed ID: 27249714
[TBL] [Abstract][Full Text] [Related]
29. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
30. Targeted Therapies for Brain Metastases from Breast Cancer.
Venur VA; Leone JP
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649142
[TBL] [Abstract][Full Text] [Related]
31. Activity of T-DM1 in Her2-positive breast cancer brain metastases.
Bartsch R; Berghoff AS; Vogl U; Rudas M; Bergen E; Dubsky P; Dieckmann K; Pinker K; Bago-Horvath Z; Galid A; Oehler L; Zielinski CC; Gnant M; Steger GG; Preusser M
Clin Exp Metastasis; 2015 Oct; 32(7):729-37. PubMed ID: 26303828
[TBL] [Abstract][Full Text] [Related]
32. Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions.
Azim HA; Azim HA
Future Oncol; 2012 Feb; 8(2):135-44. PubMed ID: 22335578
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain Metastasis.
Singh M; Venugopal C; Tokar T; McFarlane N; Subapanditha MK; Qazi M; Bakhshinyan D; Vora P; Murty NK; Jurisica I; Singh SK
Cancer Res; 2018 Sep; 78(17):5124-5134. PubMed ID: 29986997
[TBL] [Abstract][Full Text] [Related]
34. Brain Metastases in NSCLC - are TKIs Changing the Treatment Strategy?
Dempke WC; Edvardsen K; Lu S; Reinmuth N; Reck M; Inoue A
Anticancer Res; 2015 Nov; 35(11):5797-806. PubMed ID: 26504000
[TBL] [Abstract][Full Text] [Related]
35. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
[TBL] [Abstract][Full Text] [Related]
36. Applications of Genomic Sequencing in Pediatric CNS Tumors.
Bavle AA; Lin FY; Parsons DW
Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
[TBL] [Abstract][Full Text] [Related]
37. Targeted therapy for brain metastases.
Davies MA
Adv Pharmacol; 2012; 65():109-42. PubMed ID: 22959025
[TBL] [Abstract][Full Text] [Related]
38. Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.
Marini BL; Benitez LL; Zureick AH; Salloum R; Gauthier AC; Brown J; Wu YM; Robinson DR; Kumar C; Lonigro R; Vats P; Cao X; Kasaian K; Anderson B; Mullan B; Chandler B; Linzey JR; Camelo-Piragua SI; Venneti S; McKeever PE; McFadden KA; Lieberman AP; Brown N; Shao L; Leonard MAS; Junck L; McKean E; Maher CO; Garton HJL; Muraszko KM; Hervey-Jumper S; Mulcahy-Levy JM; Green A; Hoffman LM; Dorris K; Vitanza NA; Wang J; Schwartz J; Lulla R; Smiley NP; Bornhorst M; Haas-Kogan DA; Robertson PL; Chinnaiyan AM; Mody R; Koschmann C
Transl Res; 2017 Oct; 188():27.e1-27.e14. PubMed ID: 28860053
[TBL] [Abstract][Full Text] [Related]
39. Brain metastases as site of first and isolated recurrence of breast cancer: the role of systemic therapy after local treatment.
Niwińska A
Clin Exp Metastasis; 2016 Oct; 33(7):677-85. PubMed ID: 27225754
[TBL] [Abstract][Full Text] [Related]
40. Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.
Chamberlain MC; Baik CS; Gadi VK; Bhatia S; Chow LQ
Neuro Oncol; 2017 Jan; 19(1):i1-i24. PubMed ID: 28031389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
